Risk Stratification in Children With Concussion
Launched by DUKE UNIVERSITY · Apr 10, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Concussions occur at an alarming rate among U.S. schoolchildren, with one in five children experiencing a concussion by age 16. The number of children visiting emergency departments for concussions annually has increased by 50% over the past decade, with an estimated cost to the healthcare system of $1 billion/year. Compared to adults, children experience longer and more severe postconcussive symptoms (PCS). Severity and duration of PCS, however, vary considerably among children, complicating clinical care and return to learn and play. Persistent PCS including physical, emotional, and cogni...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with concussion that occurred within the past 7 days
- • Glasgow Coma Scale (GCS) score between 13-15
- • English speaking
- Exclusion Criteria:
- • Diagnosed with moderate or severe traumatic brain injury
- • Polytrauma
- • Nontraumatic brain injury
- • Pregnancy
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Karin Reuter-Rice, PhD
Principal Investigator
Duke University School of Nursing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported